These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2076202)

  • 1. Ile-Ser-bradykinin is an aberrant permeability factor in various human malignant effusions.
    Wunderer G; Walter I; Eschenbacher B; Lang M; Kellermann J; Kindermann G
    Biol Chem Hoppe Seyler; 1990 Oct; 371(10):977-81. PubMed ID: 2076202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer.
    Maeda H; Matsumura Y; Kato H
    J Biol Chem; 1988 Nov; 263(31):16051-4. PubMed ID: 3182782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y; Maeda H; Kato H
    Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Ile-Ser-bradykinin, identical with rat T-kinin, is a major permeability factor in ovarian carcinoma ascites.
    Wunderer G; Walter I; Müller E; Henschen A
    Biol Chem Hoppe Seyler; 1986 Dec; 367(12):1231-4. PubMed ID: 3828072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of malignant effusions on methotrexate disposition.
    Li J; Gwilt P
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):373-82. PubMed ID: 12439595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ile-Ser-bradykinin (T-kinin) and Met-Ile-Ser-bradykinin (Met-T-kinin) are released from T-kininogen by an acid proteinase of granulomatous tissues in rats.
    Sakamoto W; Satoh F; Gotoh K; Uehara S
    FEBS Lett; 1987 Jul; 219(2):437-40. PubMed ID: 3301404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Ile-Ser-Bradykinin degradation in human serum and ascites.
    Rehbock J; Steinhauser C; Hermann A
    Agents Actions Suppl; 1992; 38 ( Pt 1)():449-53. PubMed ID: 1466292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel kinin, Met-Ile-Ser-bradykinin (Met-T-kinin) is released from T-kininogen by an acid proteinase of granulomatous tissues in rats.
    Sakamoto W; Satoh F; Nagasawa S; Handa H; Suzuki S; Uehara S; Hirayama A
    Adv Exp Med Biol; 1989; 247B():103-8. PubMed ID: 2692410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple bradykinin-related peptides from the skin of the frog, Rana temporaria.
    Conlon JM; Aronsson U
    Peptides; 1997; 18(3):361-5. PubMed ID: 9145421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of bradykinin, kallidin and Met-Lys-bradykinin by high performance liquid chromatography.
    Geiger R; Hell R; Fritz H
    Hoppe Seylers Z Physiol Chem; 1982 May; 363(5):527-30. PubMed ID: 7095757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification, isolation and structural determination of bradykinin and hydroxyprolyl-bradykinin in tumor ascites.
    Matsumura Y; Kimura M; Kato H; Yamamoto T; Maeda H
    Adv Exp Med Biol; 1989; 247A():587-92. PubMed ID: 2640567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of a tumor-associated permeability factor in malignant effusions].
    Wunderer G
    Fortschr Med; 1989 Jan; 107(1):50. PubMed ID: 2920983
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and structure of T-kinin.
    Okamoto H; Greenbaum LM
    Biochem Biophys Res Commun; 1983 Apr; 112(2):701-8. PubMed ID: 6847671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1957-63. PubMed ID: 3718539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new kinin moiety in human plasma kininogens.
    Mindroiu T; Carretero OA; Proud D; Walz D; Scicli AG
    Biochem Biophys Res Commun; 1988 Apr; 152(2):519-26. PubMed ID: 3365237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor concentrations in body cavity effusions in dogs.
    Clifford CA; Hughes D; Beal MW; Henry CJ; Drobatz KJ; Sorenmo KU
    J Vet Intern Med; 2002; 16(2):164-8. PubMed ID: 11899032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
    Gomes RA; Juliano L; Chagas JR; Hial V
    Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assaying of tumor necrosis factor alpha, complement factors, and alpha-1-antitrypsin in the diagnosis of malignant serous effusions.
    Alexandrakis MG; Kyriakou D; Koutroubakis IE; Alexandraki R; Vlachonikolis IG; Eliopoulos GD
    Am J Clin Oncol; 2001 Dec; 24(6):562-5. PubMed ID: 11801754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two kinins formed by trypsin from human plasma protein.
    Okuda M; Arakawa K
    J Biochem; 1982 Feb; 91(2):633-41. PubMed ID: 7068581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.